Fortelyzin® in comparison with Metalyse® for ST-elevated myocardial infarction: one-year results and clinical outcomes of a multicenter randomized study FRIDOM1

Fortelyzin® in comparison with Metalyse® for ST-elevated myocardial infarction: one-year results and clinical outcomes of a multicenter randomized study FRIDOM1

Aim. Evaluate the one­year results and clinical outcomes of a multi­center randomized clinical trial FRIDOM1.Material and methods. The study FRIDOM1 was conducted in 11 clinical centers of the Russian Federation in the period 2014­2016. The study included 382 patients with acute ST­elevated myocardi...

Full description

Bibliographic Details
Main Authors: V. A. Markov, D. V. Duplyakov, S. L. Konstantinov, G. V. Klein, S. B. Aksentev, D. Yu. Platonov, E. V. Vyshlov, E. A. Ponomarev, R. M. Rabinovich, E. L. Makarov, E. V. Kulibaba, D. S. Yunevich, O. V. Kritskaia, E. A. Baranov, O. B. Talibov, E. A. Gerasimets
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2018-12-01
Series:Российский кардиологический журнал
Subjects:
st­elevated myocardial infarction
fortelyzin®
metalyse®
pharmacoinvasive strategy
one­year results
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3050

Internet

https://russjcardiol.elpub.ru/jour/article/view/3050

Similar Items